The focus of ASNC2018 meeting is to showcase current best practices, new ideas and emerging technology, radiation safety and appropriate use criteria in the nuclear cardiology clinical practice.
ASNC2018 Annual Scientific Session On Demand
Overview
This On Demand activity is comprised of sessions and presentations from the live ASNC2018 23rd Annual Scientific Meeting hosted September 6-9, 2018 in San Francisco, CA. The focus of ASNC2018meeting is to showcase current best practices, new ideas and emerging technology, radiation safety and appropriate use criteria in the nuclear cardiology clinical practice.
Important Dates
Date of Release: October 26, 2018
Date of Termination: October 25, 2019
Statement of Need
In order to maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2018 is an educational activity designed to help you and other imaging professionals obtain the latest information in clinical practice and review cutting-edge scientific advances in nuclear cardiology and cardiac imaging.
Overall Purpose: the overall goal of this activity is to enhance physician knowledge, competence and skills in applications about appropriate use criteria, radiation safety, reporting, and lab performance in using appropriate guidelines-based treatment.
Learning Objectives:
Target Audience
This online activity is intended for cardiologists, radiologists, nuclear medicine specialists, practice administrators, nuclear technologists, nurses and other health care professionals with an interest in the field of nuclear cardiology and cardiac CT imaging.
Accreditation and Continuing Education Credit
Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this enduring activity for a maximum of 50.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planners
Organizing Committee
Rob S.B. Beanlands, MD, FASNC, Chair
Firas Al Badarin, MD, FASNC
Karthikeyan Ananthasubramaniam, MD, FASNC
Timothy L. Dunn, CNMT
Donna M. Polk, MD, MPH, FASNC
Raymond R. Russell, MD, PhD, MASNC
Prem Soman, MD, PhD, FASNC
Program Committee
Sharmila Dorbala, MD, FASNC, Chair
Panithaya Chareonthaitawee, MD, Vice Chair
Mouaz Al-Mallah, MD, FASNC
James A. Arrighi, MD, MASNC
Frank Bengel, MD
Ron Blankstein, MD, FASNC
Jamieson M. Bourque, MD, FASNC
Paco Bravo, MD
Renee Bullock-Palmer, MD, FASNC
Benjamin Chow, MD, FASNC
Disclosure
As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), the American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Commercial Support. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of relevant financial relationships with commercial companies and resolution of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, moderators, and presenters involved with this activity were required to disclose any relevant financial relationships.
The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer review process.
1 designates presenter
2 designates peer reviewer/moderator
3 designates planner
The following planners, moderators, presenters, and staff reported no financial relationships:
The following planners, moderators, presenters, and staff reported financial relationships:
123Al-Mallah, Mouaz
Consulting: Yes GE Healthcare
13Ananthasubramaniam, Karthikeyan Consulting: Yes Astellas Pharma, Alnylam Pharmaceuticals: Yes Astellas Pharma, GE Healthcare, Alnylam Pharmaceuticals
Advisory Board: Yes Astellas Pharma, Alnylam Pharmaceuticals
1Arai, Andrew
Other Financial Benefit: Research agreements with Siemens and Bayer
1Axerio-Cilies, John
Salaried Employee: Yes Arterys
1Ay, Ilknur
Consulting: electroCore, LLC (unrestricted)
12Bateman, Timothy
Intellectual Property Rights: CVIT
Consulting: GEHC
Research Grant: GEHC, Astellas
Advisory Board: GEHC, Curium, IBA, AIM
Royalty: CVIT
Stock Interest: CVIT
Salaried Employee: CVIT
123Beanlands, Rob
Consulting: GE Healthcare, Lantheus, Jubilant DRAXImage
Research Grant: GE Healthcare, Lantheus, Jubilant DRAXImage
123Bengel, Frank
Honoraria: Invited Speaker for Siemens AG, GH Healthcare
Research Grant: Collaborative Research Grants with Siemens AG, GE Healthcare
123Blankstein, Ron
Consulting: Amgen, Inc.Yes Astellas, Amgen Inc.
1Bober, Robert
Consulting Fee: Bracco
Research Grant: Bracco
Advisory Board:Ionetix
13Bourque, Jamieson
Consulting: Astellas
1Calnon, Dennis
Consulting: Navidea Biopharmaceuticals
12Cerqueira, Manuel
Consulting: Astellas Pharma, GE Healthcare
Speakers Bureau: Astellas Pharma
12Case, James
Intellectual Property Rights: CVIT
Consulting: Astellas
Research Grant: Astellas
Stock Ownership: CVIT
Salaried Employee: CVIT
1Cherry, Simon
Consulting: Research Grant: United Imaging Healthcare
Advisory Board: Yes Northern California PET Imaging Center
Royalty: United Imaging Healthcare
13Chow, Benjamin
Research Grant: Research Support/Educational Support - TeraRecon Research Grant - CV Diagnostix
Stock Interest: GE
12deKemp, Robert
Consulting: Jubilant DraxImage
Research Grant: Joint University-Industry grant funding from Ontario Research Fund - Jubilant DraxImage
Royalty: Rubidium PET technologies licensed to Jubilant DraxImage; PET quantification software technologies licensed to INVIA Medical
123Dilsizian, Vasken
Consulting: Siemens, GE Healthcare
1Nakajima, Kenichi
Honoraria:FUJIFULM RI Pharma, Co. Ltd,
Research Grant: Collaborative research work with FUJIFULM RI Pharma, Co. Ltd, Japan
123Dorbala, Sharmila
Research Grant: Astellas Pharma during 2017
Stock Interest: General Electric. I have already divested myself of these stocks within the last 3 months.
123Duvall, W. Lane
Consulting: Jubilant-DraxImage, General Electric Healthcare
Advisory Board: General Electric Healthcare
123Einstein, Andrew
Consulting: GE Healthcare
Research Grant: Toshiba America Medical Systems
2Galt, James
Royalty: Royalties paid through Emory University for Emory QuantEM software for analysis of renal scintigraphy.
12Garcia, Ernest
Intellectual Property Rights: ETCb
Consulting: GE, Syntermed
Research Grant: Syntermed
Advisory Board: GE
Royalty: Syntermed for ECTb
Stock Interest: Syntermed
2Gerson, Myron
Consulting: GE Healthcare (aurora study)
Other Financial Benefit: Alter G (equipmentgrant)
1Hacker, Marcus
Consulting: Bayer, Siemens, ITG, Curium
Honoraria: Bayer, Siemens, GE Healthcare, Curium
Research Grant: Siemens, ITG
1Hage, Fadi
Consulting: Astellas, GE Healthcare
12Hansen, Christopher
Consulting: Digirad
1Harms, Hendrik
Stock: Interest: aQuant A/S
Salaried Employee: MedTrace Pharma
123Heller, Gary
Consulting: Molecualr Imaging Services, PMA Health
Advisory Board: GE Healthcare, Cell>Point
1Hendel, Robert
Speakers Bureau: Astellas Pharma
1Hyafil, Fabien
Consulting: Naogen, Iba Molecular
1Iagaru, Andrei
Consulting: GE Healthcare (paid to institution)
12Jain, Diwakar
Consulting: Astellas, Regeneron
Honoraria: Astellas, Regeneron, GLG Consulting
Research grant: Regeneron, GE
Advisory Board: Astellas
Speakers Bureau: Astellas
Stock Interest: Althera
1Krishnan, Arun
Salaried Employee: IBM Watson Health Imaging
2Maddahi, Jamshid
Consulting: GE Healthcare, Lantheus Medical Imaging
Honoraria: GE Healthcare, Lantheus Medical Imaging
Research Grant: GE Healthcare, Lantheus Medical Imaging
1Mahmarian, John
Consulting: Astellas
Speakers Bureau: Astellas
12Mann, April
Consulting: Yes Jubilant DraxImage
Honoraria: Jubilant DraxImage, Astellas
Advisory Board: Astellas
Speakers Bureau: Astellas
12Miller, Edward
Research Grant: Bracco
Advisory Board: GE
3Murthy, Venkatesh
Consulting: Ionetix
Honoraria: Ionetix
Research Grant: Siemens Medical Imaging, INVIA Medical Imaging Solutions
Advisory Board: Yes Ionetix
Stock Interest: Yes General Electric, Cardinal Health, Ionetix
123Pagnanelli, Robert
Advisory Board: Astellas
Speakers Bureau: Astellas
1Patel, Krishna
Research Grant: T32HL110837
23Poornima, Indu
Speakers Bureau: Astellas
2Renaud, Jennifer
Intellectual Property Rights: No FlowQuant - Flow quantification software
Consulting: Jubilant DraxImage Inc.
Honoraria: Jubilant DraxImage Inc.
Speakers Bureau: Jubilant DraxImage Inc.
Royalty: FlowQuant - Flow quantification software
1 Ruberg, Frederick
Consulting: Glaxo SmithKline
RGS: Eidos Therapeutics
13Russell, Raymond
Stock Interest: Spouse receives annual stock options from her employer, Novartis Institutes for Biomedical Research
Salaried Employee: Spouse employed by Novartis Institutes for Biomedical Research
123Sadeghi, Mehran
Consulting: Bracco Research USA
Salaried Employee: Yes Spouse employee of Boehringer Ingelheim
12Saeed, Ibrahim
Consulting: Yes Astellas
1Saliba, Walid
Honoraria: Biosense WebsterN
Advisory Board: Boston Scientific Atricure
2Sanghani, Rupa
Consulting: online surveys. very minimal work/reimbursement
123Shah, Nishant
Stock Interest: Yes Together, my wife and I own shares in General Electric common stock.
1Shah, Amil
Advisory Board: Philips Healthcare
1Sharma, Puneet
Stock Interest: Yes Siemens Healthineers
Salaried Employee: Yes Siemens Medical Solutions USA
1Sillanmaki, Saara
Other Financial Benefit: Educational grant from GE
123Sinusas, Albert
Intellectual Property Rights: MMP imaging w/RP805
Consulting: MicroVide, LL
Research Grant: Novartis, Merck, GE Healthcare
Advisory Board: Astellas
123Slomka, Piotr
Intellectual Property Rights: Most nuclear medicine companies
Research Grant: NIH Grant, Siemens Medical Systems
1Sohail, M. Rizwan
Consulting: Medtronic, Boston Scientific, Spectranetics, Aziyo Biologics
Research Grant: Medtronic
123Soman, Prem
Consulting: Alnylam Pharma
Research Grant: Astellas Pharma. Grant paid to the institution.
Advisory Board: Alnylam Pharma
1Stumpe, Martin
Intellectual Property Rights: Google
Stock Interest: Google
Salaried Employee: Google
12Thomas, Gregory
Research grant: to institution- Amgen (CHF trial); Research grant to institution- Novartis (CHF trial)
Speakers Bureau: Astellas Pharma
12Udelson, James
Advisory Board: Lantheus Medical Imaging, GEHC Medtrace
123Wells, R. Glenn
Honoraria: GE Healthcare
Research Grant: GE Healthcare, Advanced Accelerator Applications Inc
2Wolinsky, David
Consulting: Astellas Pharma, eViCore
Speakers Bureau: Astellas Pharma
Commercial Acknowledgement
This activity has not received commercial support.
Off Label Use
Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.
Method of Participation and CME Certificates
This product offers up to 50.5 CME credits, based on the number of hours you spend watching presentations and taking the post-test questions.
To receive CME credit for this product, you must:
1. Purchase the product
2. Read the CME front matter.
3. View the session(s) of your choosing.
4. Click the CE Information tab, and the Test button.
5. Complete the post-test. You must score 75% to earn credit. You may take the post test as many times as you need to score 75%.
6. When you are finished watching the sessions of your choosing, your certificate will reflect the total accumulated credits from the sessions. If you already claimed CME on some of these sessions during the live stream, your credit total will include those as well. Generate and print your CME certificate.
7. If you complete more tests, the certificate will update with the newly claimed credits.
Medium or Combination of Medium Used:
ASNC Scientific Session On Demand is available online on mobile devices, including smartphones and tablets.
Hardware/Software Requirements
For the most current list of system requirements, please visit http://asnc.digitellinc.com/as...
Contact Information:
For ASNC Scientific Session On Demand Customer Support:
support@digitellinc.com or (716)338-0332 ; Toll Free (877)796-1325 (U.S.A. only)
ASNC Contact Information:
American Society of Nuclear Cardiology
4340 East-West Highway, Suite 1120
Bethesda, MD 20814-4578
Phone: (301) 215-7575
Fax: (301) 215-7113
info@asnc.org
Privacy Policy
This website is provided by Digitell Inc. We do not share information about individuals with anyone other than the credit card processors and the shipping company.
The complete Privacy Policy can be found by clicking Privacy Policy at the bottom of http://asnc.digitellinc.com/as...
Bill of Rights
The American Society of Nuclear Cardiology recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill, or performance. As part of the American Society of Nuclear Cardiology’s duty to you as a learner, you have the right to expect that your continuing medical education experience with the American Society of Nuclear Cardiology includes:
Presentation 1 - A Patient with New Onset Non-ischemic Cardiomyopathy Case Presenter
Presentation 2 - A Patient with New Onset Non-ischemic Cardiomyopathy Imaging Discussant
Presentation 3 - Discussion
Presentation 4 - A Patient with Chemo/Radiation Therapy Case Presenter
Presentation 5 - A patient with Chemo/Radiation Therapy Imaging Discussant
Presentation 6 - Discussion
Presentation 7 - A Patient with Prior Cardiac Transplantation Case Presenter
Presentation 8 - A Patient with Prior Cardiac Transplantation Imaging Discussant
Presentation 9 - Discussion
Moderator(s):Presentation 1 - Dual Angiotensin Receptor-neprilysin Inhibitor Sacubitril/valsartan Attenuates 99mTc-RP805 Uptake and Systolic Dysfunction in a Rodent Model of Doxorubicin-induced Cardiotoxicity
Presentation 2 - Automatic Classification of Myocardial Perfusion Abnormalities from Nuclear Cardiac SPECT Images Using a Neural Network Model
Presentation 3 - Development and Evaluation of Novel Macrophage Elastase-targeting Radiotracers for Imaging of Aneurysms
Presentation 4 - Increase in Myocardial Matrix Metalloproteinase (MMP) Activity Detected by 99mTc-RP805 Precedes Hypertension and Cardiac Remodeling in a Rat Model of Pressure Overload and Unilateral Renal Hypoperfusion
Presentation 5 - Externally Validated Deep Learning Improves Per-vessel Prediction of Obstructive Coronary Artery Disease from Upright and Supine Spect MPI: a Multicenter Study
Moderator(s):Presentation 1 - Machine Learning, Medicine, and Imaging: The Future is Now
Presentation 2 - Discussion
Moderator(s):Presentation 1 - Cardiovascular Pathophysiology Targeted by Novel Tracers
Presentation 2 - Molecular Imaging of Aneurysms and Peripheral Arterial Disease
Presentation 3 - Imaging Device Thrombosisand DVT
Presentation 4 - Sodium Fluoride Imaging of Coronary and Valvular HeartDisease
Presentation 5 - Imaging Cardiac Inflammation Post Myocardial Infarction
Presentation 6 - Discussion
Moderator(s):Presentation 1 - Contemporary Evaluation and Management of Cardiac Amyloidosis
Presentation 2 - Case Presenter
Moderator(s):Presentation 1 - DSPECT
Presentation 2 - DNM530
Presentation 3 - Novel Reconstruction Software
Moderator(s):Discussants: Karthikeyan Ananthasubramaniam, MD, FASNC; Saurabh Malhotra, MD, MPH, FASNC
Presentation 1 - Patient Interview
Presentation 2 - Cardiac MRI and Echocardiography: Screening, Diagnosis and Prognosis per the Guidelines
Presentation 3 - PET for Cardiac Sarcoidosis: Robust Test in the Right Hands and Patients per the Guidelines
Presentation 4 - Putting it all Together: Evaluation and Management of Sarcoidosis in the Real World
Presentation 5 - Discussion
Moderator(s):Presentation 1 - National Multimodality Perspective on Registries
Presentation 2 - Impact on Clinical Activities: MIPS/QCDR
Presentation 3 - Impact on Clinical Activities: Quality/Accreditation
Presentation 4 - Impact on Directing Care and Guidelines for the Future
Presentation 5 - ImageGuide- Today and Tomorrow
Presentation 6 - Discussion
Moderator(s):Presentation 1 - The (Molecular and Cellular) Future of Cardiovascular Medicine from a Translational Scientist's Prospective
Presentation 2 - Explorer Project, Role of Whole Body PET Imaging of the Cardiovascular System
Presentation 3 - Cardiovascular Molecular Imaging in Drug Development
Presentation 4 - President-Elect's Address: What will the Future hold for Nuclear Cardiology?
Presentation 5 - Discussion